Buprenorphine 50742-0376
Product NDC
50742-0376- Manufacturer
- Ingenus Pharmaceuticals, Llc
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- November 1, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA210272
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 20 ug/h |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
4 POUCH in 1 CARTON (50742-376-04) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH